QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN)

Q: What does CUSIP 74754R103 represent in this 13F holders report?

CUSIP 74754R103 is the security identifier for QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in Q3 2022?

22 institutional investors reported QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share for Q3 2022. Use the holders table for investor-level position and value details.

CUSIP: 74754R103

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 6,138,804
Total 13F shares: 2,314,772
Share change: +39,902
Total reported value: $619,043
Price per share: $0.27
Number of holders: 22
Value change: -$2,104
Number of buys: 6
Number of sells: 3

Quarterly Holders Quick Answers

What is CUSIP 74754R103?
CUSIP 74754R103 identifies QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2022
Previous quarter: Q2 2022

Recent filing periods for CUSIP 74754R103:

Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021

Top shareholders of QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	17%	1,026,272	$584,000	—	30 Jun 2022	13F
BlackRock Finance, Inc.	13F	Company	4.2%	257,841	$147,000	—	30 Jun 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	3.7%	226,671	$129,000	—	30 Jun 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2.1%	128,900	$73,000	—	30 Jun 2022	13F
STATE STREET CORP	13F	Company	1.8%	109,314	$62,000	—	30 Jun 2022	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	1.4%	87,510	$49,000	—	30 Jun 2022	13F
HighMark Wealth Management LLC	13F	Company	1.3%	80,094	$46,000	—	30 Jun 2022	13F
FRANKLIN RESOURCES INC	13F	Company	0.9%	55,448	$32,000	—	30 Jun 2022	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.79%	48,641	$28,000	—	30 Jun 2022	13F
NORTHERN TRUST CORP	13F	Company	0.7%	43,253	$25,000	—	30 Jun 2022	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.57%	35,031	$20,000	—	30 Jun 2022	13F
WEDBUSH SECURITIES INC	13F	Company	0.52%	32,228	$18,000	—	30 Jun 2022	13F
Creative Planning	13F	Company	0.45%	27,633	$16,000	—	30 Jun 2022	13F
Kestra Advisory Services, LLC	13F	Company	0.33%	20,000	$11,000	—	30 Jun 2022	13F
CRA Financial Services, LLC	13F	Company	0.33%	19,957	$11,000	—	30 Jun 2022	13F
Bank of New York Mellon Corp	13F	Company	0.31%	18,879	$11,000	—	30 Jun 2022	13F
GROUP ONE TRADING LLC	13F	Company	0.3%	18,247	$10,000	—	30 Jun 2022	13F
Soltis Investment Advisors LLC	13F	Company	0.25%	15,439	$9,000	—	30 Jun 2022	13F
Tower Research Capital LLC (TRC)	13F	Company	0.15%	9,225	$5,000	—	30 Jun 2022	13F
US BANCORP \DE\	13F	Company	0.13%	8,243	$5,000	—	30 Jun 2022	13F
UBS Group AG	13F	Company	0.1%	5,876	$3,000	—	30 Jun 2022	13F
IFP Advisors, Inc	13F	Company	0%	1	$1,000	—	30 Jun 2022	13F
Archer Investment Corp	13F	Company	0%	160	$91	—	30 Jun 2022	13F
TD Waterhouse Canada Inc.	13F	Company	0%	8	$4	—	30 Jun 2022	13F
Michael S. Poirier	3/4/5	Chairman and CEO, Director	— class O/S missing	375,000	—	—	11 Jul 2022	3/4/5
Amy S. Broidrick	3/4/5	President/CSO, Director	— class O/S missing	130,000	—	—	11 Jul 2022	3/4/5
Tariq Arshad	3/4/5	SVP/Chief Medical Officer	— class O/S missing	102,000	—	—	11 Jul 2022	3/4/5
Christopher L. Lotz	3/4/5	Vice President of Finance, CFO	— class O/S missing	100,000	—	—	11 Jul 2022	3/4/5
Shishir K. Sinha	3/4/5	VP, COO & Secretary	— class O/S missing	100,000	—	—	11 Jul 2022	3/4/5
Wajdi Abdul-Ahad	3/4/5	Vice President, R & D, CSO	— class O/S missing	80,000	—	—	11 Jul 2022	3/4/5
Ira E. Ritter	3/4/5	Director	— class O/S missing	40,000	—	—	11 Jul 2022	3/4/5
Kurt H. Kruger	3/4/5	Director	— class O/S missing	40,000	—	—	11 Jul 2022	3/4/5
Matthew E. Korenberg	3/4/5	Director	— class O/S missing	40,000	—	—	11 Jul 2022	3/4/5
Richard A. David	3/4/5	Director	— class O/S missing	40,000	—	—	11 Jul 2022	3/4/5
Sidney W. Emery Jr.	3/4/5	Director	— class O/S missing	40,000	—	—	11 Jul 2022	3/4/5

Institutional Holders of QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN) as of Q3 2022

As of 30 Sep 2022, QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,314,772 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, COMMONWEALTH EQUITY SERVICES, LLC, HighMark Wealth Management LLC, FRANKLIN RESOURCES INC, UBS Group AG, and Raymond James Financial Services Advisors, Inc.. This page lists 22 institutional shareholders reporting positions in this security for the Q3 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

Q3 2022 holders

Holder diff

-1

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 Value $	Q3 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.